Back
Accenture Plc Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Buy
54
ACN
Accenture Plc
Last Price:
$272.33
Seasonality Move:
1.63%
Buy
67
GPCR
Structure Therapeutics, Inc.
Last Price:
$68.85
Seasonality Move:
-31.39%
Buy
54
Accenture Plc (ACN)
is a Buy
Is Accenture Plc a Buy, Sell or Hold?
-
The current Accenture Plc [ACN] share price is $269.53. The Score for ACN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
ACN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $66.74. The Score for GPCR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACN Stock Price Chart
What is Accenture Plc's stock price today?
-
The Accenture Plc share price today is $269.53Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACN is experiencing slight selling pressure.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $66.74Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.
ACN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.07 | Buy |
| Relative Strength Index (14 RSI): | 65.25 | Buy |
| Chaikin Money Flow: | -402695 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (240.65 - 261.21) | Buy |
| Bollinger Bands (100): | (238.92 - 263.04) | Buy |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.4 | Buy |
| Relative Strength Index (14 RSI): | 80.52 | Buy |
| Chaikin Money Flow: | -2951117 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.79 - 46.45) | Buy |
| Bollinger Bands (100): | (17.61 - 35.19) | Buy |
ACN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 264.16 | Buy |
| 20-day SMA: | 252.54 | Buy |
| 50-day SMA: | 248.75 | Buy |
| 200-day SMA: | 279.84 | Sell |
| 8-day EMA: | 263.83 | Buy |
| 20-day EMA: | 256.41 | Buy |
| 50-day EMA: | 252.14 | Buy |
| 200-day EMA: | 276.88 | Sell |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.28 | Buy |
| 20-day SMA: | 38.08 | Buy |
| 50-day SMA: | 32.93 | Buy |
| 200-day SMA: | 23.94 | Buy |
| 8-day EMA: | 47.33 | Buy |
| 20-day EMA: | 39.93 | Buy |
| 50-day EMA: | 33.93 | Buy |
| 200-day EMA: | 27.69 | Buy |
Accenture Plc Earnings Growth & ACN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and an increase next year of $0.94 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.14 per share.
Accenture Plc Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||